Jane Street’s Verona Pharma VRNA Stock Holding History

Jane Street’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-67,828	Closed	-$7.24M	–	12512
2025 Q3	$7.24M	Sell	67,828 -101,902	-60%	-$10.6M	﹤0.01%	2862
2025 Q2	$16.1M	Buy	169,730 +27,637	+19%	+$2.05M	﹤0.01%	1652
2025 Q1	$9.02M	Sell	142,093 -53,291	-27%	-$3.19M	﹤0.01%	2131
2024 Q4	$9.07M	Buy	195,384 +60,930	+45%	+$2.29M	﹤0.01%	1977
2024 Q3	$3.87M	Buy	134,454 +84,215	+168%	+$2.07M	﹤0.01%	3277
2024 Q2	$726K	Buy	50,239 +12,127	+32%	+$177K	﹤0.01%	6381
2024 Q1	$613K	Buy	38,112 +21,671	+132%	+$375K	﹤0.01%	6298
2023 Q4	$327K	Sell	16,441 -7,443	-31%	-$110K	﹤0.01%	7478
2023 Q3	$389K	Buy	23,884 +6,192	+35%	+$119K	﹤0.01%	6655
2023 Q2	$374K	Buy	+17,692	New	+$377K	﹤0.01%	6776
2017 Q3	–	Sell	-11,444	Closed	-$133K	–	5136
2017 Q2	$133K	Buy	+11,444	New	+$152K	﹤0.01%	4123

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jane Street's VRNA Position: Q4 2025 in Review

Jane Street sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 67,828 shares — an estimated $7.24M sold.

Jane Street first reported a position in VRNA in Q2 2017 and held it in 11 quarters. The position peaked at $16.1M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jane Street reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jane Street sold 67,828 Verona Pharma shares in Q4 2025, an estimated $7.24M.
Jane Street first reported a position in Verona Pharma in Q2 2017 and held it in 11 quarters.
Jane Street's Verona Pharma position peaked at $16.1M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.